Philippe Schoeffter

Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta

Claire Lugnier, Philippe Schoeffter, Alain Le Bec et al. · Biochemical Pharmacology · 1986 · 296 citations

Selective Inhibition, Biochemistry, Medicine +6

Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes

Christian Waeber, Philippe Schoeffter, J.M. Palacios et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1988 · 175 citations

Molecular Pharmacology, Molecular Neuroscience, Molecular Physiology +15

Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Philippe Schoeffter, Daniël Hoyer · Naunyn-Schmiedeberg s Archives of Pharmacology · 1989 · 171 citations

Medicinal Chemistry, Functional Selectivity, Medicine +5

Functional Activity of the Multiligand Analog SOM230 at Human Recombinant Somatostatin Receptor Subtypes Supports Its Usefulness in Neuroendocrine Tumors

Herbert Schmid, Philippe Schoeffter · Neuroendocrinology · 2004 · 165 citations

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells

Joost van der Hoek, Marlijn Waaijers, Peter M. van Koetsveld et al. · American Journal of Physiology-Endocrinology and Metabolism · 2005 · 152 citations · Full text

Basal Acth Release, Native Somatostatin Receptor, Subtype 2 +19